| Kelly G Gwathmey, MD | |
|
11958 W Broad St, Henrico, VA 23233-1007 | |
| (804) 828-9350 | |
| (804) 827-1744 |
| Full Name | Kelly G Gwathmey |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 17 Years |
| Location | 11958 W Broad St, Henrico, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073716775 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 0101250349 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Midlothian, VA | Home health agency |
| Medical College Of Virginia Hospitals | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcv Associated Physicians | 4385542117 | 1312 |
News Archive
A new drug has been approved to help sufferers of Crohn's disease, the U.S. Food and Drug Administration announced today. Cimzia (certolizumab pegol) received approval for adults with moderate to severe Crohn's disease who have not responded to conventional therapies. This product was approved with a Medication Guide.
BSP Biological Signal Processing Ltd. (BSP), which develops and manufactures products for the non-invasive, accurate diagnosis of Coronary Artery Disease (CAD), recently announced the successful completion of a comprehensive clinical research study evaluating the performance of the company's HyperQ technology in diagnosing CAD.
Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
› Verified 3 days ago
| Entity Name | Mcv Associated Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710959457 PECOS PAC ID: 4385542117 Enrollment ID: O20031230000559 |
News Archive
A new drug has been approved to help sufferers of Crohn's disease, the U.S. Food and Drug Administration announced today. Cimzia (certolizumab pegol) received approval for adults with moderate to severe Crohn's disease who have not responded to conventional therapies. This product was approved with a Medication Guide.
BSP Biological Signal Processing Ltd. (BSP), which develops and manufactures products for the non-invasive, accurate diagnosis of Coronary Artery Disease (CAD), recently announced the successful completion of a comprehensive clinical research study evaluating the performance of the company's HyperQ technology in diagnosing CAD.
Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
› Verified 3 days ago
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
A new drug has been approved to help sufferers of Crohn's disease, the U.S. Food and Drug Administration announced today. Cimzia (certolizumab pegol) received approval for adults with moderate to severe Crohn's disease who have not responded to conventional therapies. This product was approved with a Medication Guide.
BSP Biological Signal Processing Ltd. (BSP), which develops and manufactures products for the non-invasive, accurate diagnosis of Coronary Artery Disease (CAD), recently announced the successful completion of a comprehensive clinical research study evaluating the performance of the company's HyperQ technology in diagnosing CAD.
Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly G Gwathmey, MD Po Box 91734, Richmond, VA 23291-1734 Ph: (804) 358-6100 | Kelly G Gwathmey, MD 11958 W Broad St, Henrico, VA 23233-1007 Ph: (804) 828-9350 |
News Archive
A new drug has been approved to help sufferers of Crohn's disease, the U.S. Food and Drug Administration announced today. Cimzia (certolizumab pegol) received approval for adults with moderate to severe Crohn's disease who have not responded to conventional therapies. This product was approved with a Medication Guide.
BSP Biological Signal Processing Ltd. (BSP), which develops and manufactures products for the non-invasive, accurate diagnosis of Coronary Artery Disease (CAD), recently announced the successful completion of a comprehensive clinical research study evaluating the performance of the company's HyperQ technology in diagnosing CAD.
Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
› Verified 3 days ago
Dr. Ryan Canissario, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11958 W Broad St, Henrico, VA 23233 Phone: 804-828-9350 | |
Dr. Scott Robert Haines, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11958 W Broad St, Henrico, VA 23233 Phone: 804-360-4669 Fax: 804-364-6697 | |
Qihua Fan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11958 W Broad St, Henrico, VA 23233 Phone: 804-828-9350 Fax: 804-364-6521 | |
Matthew J. Barrett, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11958 W Broad St, Henrico, VA 23233 Phone: 804-828-9350 Fax: 804-364-6521 |